Replay establishes distinguished Scientific Advisory Board of genomic medicine and cell therapy experts
San Diego, California and London, UK, October 17, 2022 – Replay, a genome writing company reprogramming biology by writing and delivering big DNA, today announced that it has established a scientific advisory board (SAB) comprising ten experts across a broad range of areas of scientific importance in genomic medicine and cell therapy. The newly formed SAB will provide input into […]
How Stem Cells Can Treat Avascular Necrosis – Yale Medicine Explains
Dr. Wiznia explains what avascular necrosis is and how stem cells can treat this condition. Video Transcript: Stem cells are really important because they give us the ability to regenerate. We have cells in our bone marrow that are stem cells that then can become new blood vessels, new muscle, new bone. Orthopedics is very […]
Discover Medical Advances in Cellular Therapy Research Using Cord Blood for Cancer, HIV, Cerebral Palsy and Autism During World Cord Blood Day 2022
Free virtual conference for World Cord Blood Day 2022 (November 15th) to feature renowned transplant doctors and researchers presenting ground-breaking work in cellular therapy using cord blood to treat cancer, HIV, cerebral palsy and autism. In addition, bestselling author, Delia Ephron, to present her memoir about fighting leukemia, “Left on 10th: A Second Chance at Life.” […]
BREAKTHROUGH TECHNOLOGY FOR IPS-DERIVED CELL THERAPIES TURNED INTO GMP PLATFORM BY TREEFROG THERAPEUTICS & INVETECH
BORDEAUX, France, Oct. 11, 2022 /PRNewswire/ — TreeFrog Therapeutics, a biotechnology company developing stem cell-derived therapies in regenerative medicine and immuno-oncology based on the biomimetic C-Stem™ technology platform, and Invetech, a global leader in the development and production of automated manufacturing solutions for cell and advanced therapies, today announced the delivery of a GMP-grade cell encapsulation device using the C-Stem™ technology. […]
Orchard Announces Multiple Presentations at 2022 ESGCT Annual Congress Showing the Potential of HSC Gene Therapy in Several Therapeutic Areas
BOSTON and LONDON, Oct. 10, 2022 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced multiple presentations at the 29th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT), taking place October 11-14, 2022, in Edinburgh. Clinical and pre-clinical data from across the company’s hematopoietic stem cell […]
Searching for a Spina Bifida Cure Part 1 – The Promise of Stem Cells
The first ever in utero stem cell treatment for spina bifida is the culmination of decades of work from UC Davis surgeon-scientist Diana Farmer. This novel fetal surgery at UC Davis Children’s Hospital could change the life of a developing baby with spina bifida, who otherwise could be born paralyzed from the waist down. In […]
ANDREWS MEDICINE AND CELLTEX THERAPEUTICS CORPORATION JOIN FORCES TO BRING CUTTING EDGE TECHNOLOGIES TO ATHLETIC INJURIES
HOUSTON, Oct. 4, 2022 /PRNewswire/ — James R. “Jim” Andrews, MD, Chairman and CEO of Andrews Medicine of Pensacola, Florida, and David G. Eller, Chairman and CEO of Celltex Therapeutics Corporation of Houston, Texas, announced today that together they will form a new biotechnology company to bridge the divide between stem cell research and the […]
FDA Loses Stem Cell Therapy Lawsuit
Dr. Bill Johnson of Innovations Medical in Texas explains the decision the FDA made in 2018 regarding stem cells and how it restricted their use in the United States. Watch this short video for the good news regarding the ruling that the Federal Court recently made. Video Transcript: Hi. I’m Dr Bill Johnson of Innovations […]
Are Stem Cell Injections Covered by Medicare
Stem cell injections are a popular treatment for various conditions, but are they covered by Medicare? The answer is maybe. Medicare will cover stem cell injections if they are considered medically necessary and if the patient receiving the treatment meets certain criteria. However, here is some important information from Dr. Centeno that you should be […]
Kadimastem Receives Approval of Patent Registration for Its Cell Selection and Enrichment Technology Used to Develop Its IsletRx Treatment for Diabetes in a Third Territory
NESS ZIONA, Israel, Sept. 28, 2022 /PRNewswire/ — Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing treatments for ALS and diabetes, has been granted its third patent approval for the company’s innovative cell selection and enrichment technology and its use in the production of IsletRx, the company’s treatment and potential cure for diabetes. […]